Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Published in: International Journal of Hematology 4/2004

01-11-2004

Echocardiographic and Electrocardiographic Prognostic Factors of Heart Failure in Young Patients with ß-Thalassemia Major: A 10-Year (1995—2004) Follow-up

Authors: Christina Chrysohoou, Demosthenes B. Panagiotakos, Yannis Barbetseas, Stella Brilli, Spyros Lambrou, Markissia Karagiorga, Vassilis A. Ladis, Christos Pitsavos, Christodoulos Stefanadis

Published in: International Journal of Hematology | Issue 4/2004

Login to get access
Metadata
Title
Echocardiographic and Electrocardiographic Prognostic Factors of Heart Failure in Young Patients with ß-Thalassemia Major: A 10-Year (1995—2004) Follow-up
Authors
Christina Chrysohoou
Demosthenes B. Panagiotakos
Yannis Barbetseas
Stella Brilli
Spyros Lambrou
Markissia Karagiorga
Vassilis A. Ladis
Christos Pitsavos
Christodoulos Stefanadis
Publication date
01-11-2004
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 4/2004
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1532/IJH97.E0407

Other articles of this Issue 4/2004

International Journal of Hematology 4/2004 Go to the issue

OriginalPaper

Case of Chronic Lymphocytic Leukemia with Unusual Chromosome Aberrations

OriginalPaper

The Rationale for Pathogen-Inactivation Treatment of Blood Components

OriginalPaper

Cotransplantation of Marrow Stromal Cells May Prevent Lethal Graft-versus-Host Disease in Major Histocompatibility Complex Mismatched Murine Hematopoietic Stem Cell Transplantation

OriginalPaper

A Randomized Controlled Trial Investigating the Survival Benefit of Dose-Intensified Multidrug Combination Chemotherapy (LSG9) for Intermediate- or High-Grade Non-Hodgkin’s Lymphoma: Japan Clinical Oncology Group Study 9002

OriginalPaper

Characterization of a Novel Nonsense Mutation in the Interleukin-7 Receptor α Gene in a Korean Patient with Severe Combined Immunodeficiency

OriginalPaper

Primary Cutaneous Plasmacytoma after Rejection of a Transplanted Kidney: Case Report and Review of the Literature
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits